MOTS-c
? Investigational
Peptide Database
Tesamorelin
An FDA-approved synthetic GHRH analog with a narrow but real indication: reducing excess visceral abdominal fat in HIV-infected patients on antiretroviral therapy.
PT-141 (Bremelanotide)
An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder (HSDD) in premenopausal women.
Semax
⊘ Insufficient evidence
Selank
⊘ Insufficient evidence
Epithalon
Epithalon (also known as Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson and colleagues. It was designed as a simplified, more stable…
Growth Hormone-Releasing Peptide-6
GHRP-6 is a synthetic, first-generation hexapeptide growth hormone secretagogue (GHS). It was developed in the 1980s through systematic modification of the met-enkephalin structure to create…
Growth Hormone-Releasing Peptide-2
GHRP-2 is a synthetic, potent, and selective hexapeptide growth hormone secretagogue (GHS). It was developed in the late 1980s and early 1990s as part of…
CJC-1295
A modified GHRH (growth hormone-releasing hormone) analog with two distinct forms in circulation: with-DAC and without-DAC.
Ipamorelin
A selective growth hormone secretagogue (GHRP) — pentapeptide that stimulates GH release through the ghrelin receptor without the cortisol or prolactin elevation seen with older…